IBD ETF

IBD ETF
$23.53
See how much of IBD you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Returns Overview

1 Month
-0.97%
3 Months
-0.89%
6 Months
-1.02%
YTD
-0.69%
1 Year
+2.02%
3 Years (annualized)
+4.91%
5 Years (annualized)
+0.99%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would IBD have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
Bloomberg US Intermediate Corporate Bond Index(^BBGUSINCBI)
This ETF (YTD)
-0.69%
Peer Avg (YTD)
+0.12%
vs Peers
-0.81%

IBD ETF Performance

IBD performance across multiple time periods: 1-month -0.97%, YTD -0.69%, 1-year 2.02%, 3-year 4.91%, 5-year 0.99%.

IBD returns trail the peer average of 0.12% YTD. With an expense ratio of 0.41%, investors should weigh costs against performance when evaluating this ETF.

IBD vs another fund shows side-by-side returns. IBD alternatives are available in the ETF Screener.

Compare IBD

IBD vs SPYIBD vs QQQIBD vs VOOIBD vs VTIIBD vs IVVIBD vs SCHDIBD vs VYMIBD vs VXUS

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-0.97%N/A
3 Months-0.89%N/A
6 Months-1.02%N/A
1 Year+2.02%N/A
3 Years+4.91%N/A
5 Years+0.99%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized